TownSquare Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $257K | Buy |
1,638
+81
| +5% | +$12.1K | 0.05% | 242 |
|
|
2026
Q1 | $238K | Buy |
+1,557
| New | +$239K | 0.05% | 226 |
|
|
2025
Q4 | – | Sell |
-1,894
| Closed | -$243K | – | 323 |
|
|
2025
Q3 | $243K | Sell |
1,894
-3,966
| -68% | -$484K | 0.04% | 322 |
|
|
2025
Q2 | $709K | Sell |
5,860
-84,992
| -94% | -$9.58M | 0.07% | 275 |
|
|
2025
Q1 | $10.1M | Buy |
90,852
+799
| +0.9% | +$85.1K | 0.11% | 180 |
|
|
2024
Q4 | $8.76M | Buy |
90,053
+47,294
| +111% | +$5.04M | 0.1% | 191 |
|
|
2024
Q3 | $4.92M | Buy |
42,759
+11,866
| +38% | +$1.35M | 0.06% | 302 |
|
|
2024
Q2 | $3.29M | Buy |
30,893
+5,545
| +22% | +$557K | 0.04% | 364 |
|
|
2024
Q1 | $2.45M | Buy |
25,348
+10,222
| +68% | +$1.05M | 0.04% | 414 |
|
|
2023
Q4 | $1.53M | Sell |
15,126
-10,529
| -41% | -$1.02M | 0.03% | 482 |
|
|
2023
Q3 | $2.61M | Sell |
25,655
-2,570
| -9% | -$261K | 0.05% | 339 |
|
|
2023
Q2 | $2.85M | Buy |
28,225
+14,852
| +111% | +$1.49M | 0.05% | 312 |
|
|
2023
Q1 | $1.23M | Sell |
13,373
-7,090
| -35% | -$619K | 0.03% | 426 |
|
|
2022
Q4 | $1.86M | Buy |
20,463
+3,838
| +23% | +$323K | 0.05% | 323 |
|
|
2022
Q3 | $1.26M | Sell |
16,625
-88
| -0.5% | -$7.29K | 0.04% | 322 |
|
|
2022
Q2 | $1.41M | Buy |
16,713
+4,464
| +36% | +$392K | 0.04% | 296 |
|
|
2022
Q1 | $1.07M | Buy |
12,249
+3,600
| +42% | +$312K | 0.03% | 335 |
|
|
2021
Q4 | $757K | Sell |
8,649
-1,732
| -17% | -$144K | 0.02% | 397 |
|
|
2021
Q3 | $849K | Buy |
10,381
+4,596
| +79% | +$413K | 0.02% | 366 |
|
|
2021
Q2 | $530K | Buy |
5,785
+2,769
| +92% | +$247K | 0.02% | 413 |
|
|
2021
Q1 | $258K | Sell |
3,016
-14,669
| -83% | -$1.32M | 0.01% | 504 |
|
|
2020
Q4 | $1.67M | Buy |
17,685
+441
| +3% | +$38.5K | 0.07% | 207 |
|
|
2020
Q3 | $1.49M | Buy |
17,244
+4,311
| +33% | +$373K | 0.09% | 182 |
|
|
2020
Q2 | $1.11M | Buy |
12,933
+4,359
| +51% | +$376K | 0.08% | 187 |
|
|
2020
Q1 | $715K | Sell |
8,574
-3,027
| -26% | -$270K | 0.06% | 216 |
|
|
2019
Q4 | $1.1M | Sell |
11,601
-215
| -2% | -$19.3K | 0.09% | 165 |
|
|
2019
Q3 | $1.03M | Buy |
11,816
+2,290
| +24% | +$206K | 0.09% | 178 |
|
|
2019
Q2 | $878K | Sell |
9,526
-544
| -5% | -$46K | 0.08% | 183 |
|
|
2019
Q1 | $868K | Buy |
10,070
+5,786
| +135% | +$464K | 0.07% | 195 |
|
|
2018
Q4 | $341K | Buy |
+4,284
| New | +$333K | 0.04% | 274 |
|
Other funds holding NVS
TownSquare Capital's NVS Position: Q2 2026 in Review
TownSquare Capital increased its Novartis (NVS) stake by 5.2% in Q2 2026, buying an estimated $12.1K and bringing the position to 1,638 shares worth $257K. The position accounts for 0.05% of the portfolio, ranked #242.
TownSquare Capital first reported a position in NVS in Q4 2018 and has held it in 30 quarters since. The position peaked at $10.1M in Q1 2025. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- TownSquare Capital held 1,638 shares of Novartis worth $257K as of Q2 2026.
- TownSquare Capital bought 81 Novartis shares in Q2 2026, an estimated $12.1K.
- Novartis made up 0.05% of TownSquare Capital's portfolio in Q2 2026, its #242 holding.
- TownSquare Capital first reported a position in Novartis in Q4 2018 and has held it in 30 quarters since.
- TownSquare Capital's Novartis position peaked at $10.1M in Q1 2025.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on TownSquare Capital's 13F filing for Q2 2026, filed 14 Aug 2026.